Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
EquiReason serves as a comprehensive platform for equity research and market intelligence, catering to self-directed investors, independent analysts, and research teams alike. By integrating SEC filings, XBRL financial data, earnings-call transcripts, and extensive market information, it empowers users to analyze financial performance, ownership trends, and overall company exposure. The platform meticulously tracks market events through economic channels, linking them to potentially impacted companies and offering a verdict for each, complete with supporting and counter-arguments. Users can access a variety of research perspectives, which include financial statements, valuation insights, insider and institutional activities, segment revenue details, and alerts specific to each company, with all evidence connected to its original source. Accessible via both web and iPhone app, EquiReason features a free plan alongside paid research options, ensuring users have the necessary tools for informed decision-making. Importantly, the platform focuses on providing research and decision support rather than direct investment advice, enabling users to navigate the complexities of the market with greater confidence.
Description
FN2 functions as an independent stock decision-making engine, designed to relieve you from the repetitive daily research tasks. Rather than engaging in the same research cycle each morning, FN2 employs AI agents that actively monitor the markets, conduct in-depth research according to a set schedule, and send their findings directly to your Inbox, Phone, or Discord.
You can express your tracking preferences in plain language, whether it's a specific ticker, a sector, a particular thesis, or a question like "notify me when NVDA's guidance changes," or you can select from a range of pre-configured agents. FN2 then transforms your input into an autonomous research agent that operates on your timeline—be it before market open, immediately following earnings reports, or on a weekly basis. Each agent meticulously analyzes earnings-call transcripts, retrieves macroeconomic data from FRED, evaluates tickers, creates visual charts, and synthesizes all this information to provide you with a decision-ready summary instead of just a collection of raw data. This means no more juggling multiple tabs, no reliance on screeners, and no need to conduct manual morning research. FN2 is specifically designed for dedicated individual investors and analysts who find themselves overwhelmed by the sheer volume of tabs, transcripts, and screeners resulting from repetitive daily tasks. By streamlining the research process, FN2 allows you to focus on making informed investment decisions with greater efficiency and ease.
API Access
Has API
Yes
API Access
Has API
No
Screenshots View All
No images available
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Trial
Yes
Free Version
Yes
Pricing Details
$30/month
Free Trial
No
Free Version
Yes
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
Yes
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
EquiReason
Founded
2026
Country
Turkey
Website
equireason.com
Vendor Details
Company Name
FN2
Founded
2026
Country
United States
Website
fn2.ai
Product Features
Product Features
Alternatives
No Alternatives